London Calling 2025 - Speakers
Speakers
Check out the line up of speakers at London Calling 2025.
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
Oxford Nanopore Technologies
Mashiat Mimosa
)
- Job title
- Institution
- University of Toronto, Canada
- Biography
Mashiat Mimosa is a PhD student in the Department of Laboratory Medicine and Pathobiology at the University of Toronto in Canada, under the supervision of Dr Rola Saleeb and Dr Ramzi Fattouh. She earned her BSc (honours) in Neuroscience and Molecular Biology, Immunology, and Disease from the University of Toronto, where she developed a deep interest in genomics and oncology. Mashiat’s PhD research focuses on developing novel brain cancer diagnostic and classification tests to improve the lives of cancer patients.
- Recent publications
Mimosa, M. L. et al. Detecting chromosomal copy number variations and point mutations in Glioma using a single assay; sparing tissue while significantly reducing testing time and cost [abstract]. Cancer Res. 84 (6_Supplement): 5049 (2024).
DOI: 10.1158/1538-7445.AM2024-5049Mimosa, M.L. et al. A Novel Approach to Detect IDH Point mutations in Gliomas Using Nanopore Sequencing, Test Validation for The Clinical Laboratory. Journal of Molecular Diagnostics 25(3):133-142 (2023).
DOI: 10.1016/j.jmoldx.2022.12.001
Talks at this conference
Oxford Nanopore Technologies products are RUO. Products labelled/branded as Oxford Nanopore Diagnostics may be RUO or may be regulated as in-vitro diagnostic devices in some jurisdictions, please check individual product labelling. Oxford Nanopore Technologies present the materials of third parties within the user community acknowledging that those materials belong to and are the true statements and representations of those third parties. Oxford Nanopore Technologies make no endorsements of the materials shown and the statements made.